FlanaxPlus Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Per g Piroxicam 5 mg, methyl salicylate 102 mg, menthol 54.3 mg, eugenol 13.7 mg

Indications/Uses

Relief of pain & local treatment of OA & arthrosis.

Click to view FlanaxPlus detailed prescribing information

Dosage/Direction for Use

Apply to the affected area tid-qid.

Click to view FlanaxPlus detailed prescribing information

Overdosage

View FlanaxPlus overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity. Open wound at the affected area, or injured or damaged skin.

Click to view FlanaxPlus detailed prescribing information

Special Precautions

Discontinue use if irritation or hypersensitivity develops. Do not use concomitantly w/ another dosage form of piroxicam, methyl salicylate, menthol or eugenol. Avoid contact w/ the eyes & mucous membranes & avoid direct application into nostrils. Do not apply over large areas of the body or bandage or use w/ heating pads. Safety during pregnancy has not been established. Not recommended during lactation. Not recommended in childn.

Click to view FlanaxPlus detailed prescribing information

Use In Pregnancy & Lactation

Click to view FlanaxPlus detailed prescribing information

Adverse Reactions

Mild to moderate local irritation, erythema, rash, pityroid desquamation, pruritus, & related local reactions at the application site. Mild but transient skin discoloration & staining of clothing.

Click to view FlanaxPlus detailed prescribing information

Storage

View FlanaxPlus storage conditions for details to ensure optimal shelf-life.

Description

View FlanaxPlus description for details of the chemical structure and excipients (inactive components).

Action

View FlanaxPlus mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

ATC Classification

M02AA07 - piroxicam ; Belongs to the class of non-steroidal antiinflammatory preparations for topical use. Used in the treatment of joint and muscular pains.

Regulatory Classification

Non-Rx

Presentation/Packing

Form

FlanaxPlus topical gel

Packing/Price

25 g x 1's;50 g x 1's (P219.75/box)

FlanaxPlus

Manufacturer:

Taisho

Distributor:

Taisho